OTC Industry News – Production – Manufacturing – Pharmaceutical Business Review #recent #pharmaceutical #news


Posted On Aug 13 2017 by

#pharmaceutical business

#

On 30 June, Moberg Pharma announced the acquisition of three Over-The-Counter brands in the U.S. from Prestige Brands. The acquisition has now been completed. The purchase price amounted to $40 million.
Production Manufacturing OTC News

Galderma’s U.S. affiliate, Galderma Laboratories received approval from the U.S. Food and Drug Administration (FDA) for Differin Gel (adapalene gel 0.1%) as an over-the-counter (OTC) treatment for acne.
Production Manufacturing OTC News

Moberg Pharma has signed an agreement to acquire New Skin, Fiber Choice and PediaCare, three well-established Over-The-Counter brands in the U.S. from Prestige Brands.
Production Manufacturing OTC News

VANC Pharmaceuticals, a pharmaceutical company focused on the Canadian generic drug and over-the-counter market, has entered into a definitive agreement for filing two abbreviated new drug submissions (ANDS) with exclusive marketing rights to Canada from an unnamed, manufacturer.
Production Manufacturing OTC News

The US Food and Drug Administration (FDA) is warning consumers about the risk of severe bleeding when using over-the-counter (OTC) aspirin-containing antacid products.
Production Manufacturing OTC News

Dr. Reddy’s Laboratories has acquired a portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories.
Production Manufacturing OTC News

Mylan has agreed to acquire the non-sterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings for about $1bn.
Production Manufacturing OTC News

Perrigo has received final US Food and Drug Administration (FDA) approval for the generic version of Valeant Pharmaceutical International’s BenzaClin Pump Topical Gel.
Production Manufacturing OTC News

Health Canada has approved Vanc Pharmaceuticals’ Cortivera-H, a premium topical product for minor skin irritations.
Production Manufacturing OTC News

BioPharmX has completed enrollment for its Phase 2a study of the novel topical minocycline gel BPX-01.
Production Manufacturing OTC News





Last Updated on: August 13th, 2017 at 12:40 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *